Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome

New England Journal of Medicine

Volumn 337, Issue 25, 1997, Pages 1807-1812

  Motte, Jacques ^a   Trevathan, Edwin ^b   Arvidsson, Jan F V ^c   Barrera, Manuel Nieto ^d   Mullens, E Lynette ^e   Manasco, Penelope ^f  

^a AMERICAN MEMORIAL HOSPITAL   (France)

^b UNIVERSITY OF KENTUCKY   (United States)

^c RYHOV COUNTY HOSPITAL   (Sweden)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e GLAXOSMITHKLINE   (United Kingdom)

^f GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; PLACEBO; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; COMMON COLD; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROENCEPHALOGRAM; FEMALE; GRAND MAL SEIZURE; HUMAN; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; HUMANS; MALE; MENTAL RETARDATION; SEIZURES; SYNDROME; TREATMENT OUTCOME; TRIAZINES;

EID: 0031453973     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199712183372504     Document Type: Article

References (30)

1. Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsia 1994;35:Suppl 2:S1-S6.
2. Trevathan E, Murphy CC, Yeargin-Allsopp M. The epidemiology of Lennox-Gastaut syndrome among Atlanta children. Epilepsia 1997;38(12): 1283-8.
3. Aicardi J. Epileptic encephalopathies of early childhood. Curr Opin Neurol Neurosurg 1992;5:344-8.
4. Fitzgerald LF, Stone JL, Hughes JR, Melyn MA, Lansky LL. The Lennox-Gastaut syndrome: electroencephalographic characteristics, clinical correlates, and follow-up studies. Clin Electroencephalogr 1992;23:180-9.
5. Gastaut H, Roger J, Soulayrol R, et al. Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as "petit-mal variant") or Lennox syndrome. Epilepsia 1966;7:139-79.
6. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
7. The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
8. Shields WD. Investigational antiepileptic drugs for the treatment of childhood seizure disorders: a review of efficacy and safety. Epilepsia 1994; 35:Suppl 2:S24-S29.
9. Peck AW. Lamotrigine: historical background. Rev Contemp Pharmacother 1994;5:95-105.
10. Goa KL, Ross SR, Chrisp P. Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993;46:152-76.
11. Meldrum B, Leach M. The mechanisms of action of lamotrigine. Rev Contemp Pharmacother 1994;5:107-14.
12. Messenheimer J, Ramsay RE, Willmore LJ, et al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, crossover trial. Epilepsia 1994;35:113-21.
13. Binnie CD, Debets RM, Engelsman M, et al. Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res 1989;4:222-9.
14. Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989;30:356-63.
15. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures: U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology 1993;43:2284-91.
16. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34: 312-22.
17. Brodie MJ, Richens A, Yuen AWC. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345: 476-9.
18. Besag FM, Wallace SJ, Dulac O, Alving J, Spencer SC, Hosking G. Lamotrigine for the treatment of epilepsy in childhood. J Pediatr 1995;127: 991-7.
19. Uvebrant P, Bauziene R. Intractable epilepsy in children: the efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics 1994;25:284-9.
20. Buchanan N. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability. Seizure 1995;4:233-6.
21. Timmings PL, Richens A. Lamotrigine as add-on drug in the management of Lennox-Gastaut syndrome. Eur Neurol 1992;32:305-7.
22. Schlumberger E, Chavez F, Palacios L, Rey E, Pajot N, Dulac O. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 1994;35: 359-67.
23. May TW, Rambeck B, Jurgens U. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication. Ther Drug Monit 1996;18:523-31.
24. Anderson GD, Yau MK, Gidal BE, et al. Bidirectional interaction of valproate and lamotrigine in healthy subjects. Clin Pharmacol Ther 1996; 60:145-56.
25. van Elteren PH. On the combination of independent two sample tests of Wilcoxon. Bull Int Stat Inst 1960;37:351-61.
26. Donaldson JA, Glauser TA, Olberding LS. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome). Epilepsia 1997;38:68-73.
27. Felbatol product information. Cran bury, N.J.: Wallace Laboratories, 1994.
28. Mackay FJ, Wilton LV, Pearce GL, Freemantle SN, Mann RD. Safety of long-term lamotrigine in epilepsy. Epilepsia 1997;38:881-6.
29. Besag FM, Dulac O, Alving J, Mullens EL. Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy. Seizure 1997;6:51-6.
30. Gibaldi M, Sullivan S. Intention-to-treat analysis in randomized trials: who gets counted? J Clin Pharmacol 1997;37:667-72.